期刊文献+

肝硬化肝性脑病患者预后的相关因素分析 被引量:2

Analysis of cirrhosis patients with hepatic encephalopathy prognostic factors
暂未订购
导出
摘要 目的探讨肝硬化肝性脑病(HE)患者的预后相关因素。方法回顾性分析收治的84例肝硬化肝性脑病患者,将治疗后好转的36例患者作为对照组,治疗后恶化死亡的48例患者作为观察组,观察比较两组患者在感染,血氨、血肌酐、血清蛋白、血钾、血钠、甲状腺激素水平的差异。结果两组患者在胆红素异常(44.4%vs66.7%)、血钠异常(16.7%vs37.5%)、HE分期(43.6%vs25.0%)、感染(33.3%vs54.2%)等诱因比较中,差异均有统计学意义(P<0.05);在血氨异常、血清蛋白异常、血钾异常、凝血酶原时间、血肌酐异常方面差异无统计学意义(P>0.05)。Logistic回归分析显示,HE分期、Child分级、消化道出血、血钠及血肌酐均为对肝硬化患者预后具有影响的独立危险因素。结论感染等诱因的多少与肝硬化肝性脑病患者的预后密切相关,且HE分期、血肌酐、血钠是影响肝硬化肝性脑病的危险因素。 Objective To investigate the prognostic factors in the analysis of cirrhosis patients with hepatic encephalopathy(HE). Methods Retrospective analysis was conducted on 84 cirrhosis patients with HE, 36 patients who improved after treatment were taken as the control group, the deterioration in the death of 48 patients after treatment were taken as observed group, the differences in infection, blood ammonia, serum creatinine, serum protein, serum potassium, serum sodium, thyroid hormone levels were compared between two groups. Results The patients in the comparison of bilirubin(44.4% vs 66.7%),serum sodium(16.7% vs 37.5%),HE stage(43.6% vs 25.0%), infection (33.3 % vs 54.2 %), and other incentives factors showed significant difference ( P 〈 0.05);the difference of blood ammonia, serum protein, serum potassium, prothromhin time and serum creatinine showed no statistic significance( P 〈 0.05). Multivariate logistic analysis showed that HE stage, Child grade, digestive tract bleeding, serum sodium and serum creatinine may be independent risk factors for the prognosis of cirrhosis patients. Conclusion Infection and other factors in some degree is closely related with the prognosis of cirrhosis of the liver in patients with HE,and HE grade, serum creatinine,serum sodium are risk factors affecting the hepatic encephalopathy.
出处 《临床荟萃》 CAS 2013年第4期406-408,共3页 Clinical Focus
关键词 肝硬化 肝性脑病 预后 liver cirrhosis hepatic encephalopathy prognosis
  • 相关文献

参考文献7

二级参考文献51

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:732
  • 2张俊勇,王宝恩,贾继东.终末期肝病模型评分与肝移植[J].中华肝脏病杂志,2005,13(3):235-237. 被引量:10
  • 3吴雄健,舒建昌.86例肝性脑病患者诱因与预后关系分析[J].中国医师进修杂志,2006,29(4):61-61. 被引量:2
  • 4保志军,邱德凯,马雄,张赣生,范竹萍,黄一沁,于晓峰,曾民德.轻微肝性脑病的生命质量评价[J].中华肝脏病杂志,2007,15(6):412-416. 被引量:10
  • 5陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 6Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.
  • 7Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 8Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl, 2002, 8: 851-858.
  • 9Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J].Hepatology,1996;23(1):164-76.
  • 10Cardenas A,Gines P,Uriz J,et al.Renal failure after upper gastrointestinal bleeding in cirrhosis:incidence,clinical course,predictive factors,and short-term prognosis[J].Hepatology,2001 ;34(4):671-6.

共引文献62

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部